Newsroom

In the News

• Cellarity Expands Leadership Team to Continue Evolution of a Breakthrough Platform to Encode Biology and Purposefully Create New Medicines

  02.10.2022

• The Future of Biotech in an Artificially Intelligent World

  01.06.2022

• Cellarity Appoints Biopharmaceutical Executive Ian Estepan to its Board of Directors

  12.08.2021

• 5 Up-and-Coming Biotech Startups Worth Watching

  10.07.2021

• Decoding cell behavior and disease with AI and single-cell transcriptomics

  10.06.2021

• Fierce Biotech names Cellarity as one of its “Fierce 15” Biotech Companies of 2021

  09.27.2021

• Cellarity Bolsters Executive Team with Appointment of Top-Ranked Wall Street Analyst David Risinger as Chief Financial Officer

  07.20.2021

• Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target

  02.25.2021

• Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity

  07.16.2020

• Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics

  12.11.2019

• Flagship Pioneering launches Cellarity for cell behaviour-targeting drugs

  12.11.2019

• Flagship’s Cellarity maps out network-based drug discovery

  12.10.2019

• Flagship Pioneering Launches New Company to Discover Medicines Targeting Cellular Behavior | BioSpace

  12.10.2019

• Flagship Pioneering's Cellarity Exits Stealth Mode to Discover Drugs Using Cell Behavior

  12.10.2019

• Cellarity, Flagship's $50M bet on Network Biology, Marries Machine Learning and Single-Cell Tech for Drug Discovery

  12.10.2019

• Fierce Biotech | Flagship Company Cellarity Takes Aim at Cell Behavior

  12.10.2019

• Flagship Pioneering Unveils Cellarity, the First Company to Discover Medicines Targeting Cell Behavior

  12.09.2019

• Can Machines Understand Complex Biology?

  10.23.2019